Market Tracker

01/20 5:16pm ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.02
Delayed Data
As of Jan 20
 +0.02 / +0.50%
Today’s Change
2.63
Today|||52-Week Range
6.30
+11.05%
Year-to-Date

Today’s Trading

Previous close4.00
Today’s open4.03
Day’s range3.89 - 4.08
Volume108,885
Average volume (3 months)72,744
Market cap$83.9M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+34.21%
Earnings growth (this year)+18.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-46.62%
P/E ratioNM
Price/Sales21.38
Price/Book5.30

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...-0.47-9.46%
ORMPOramed Pharmaceutica...+0.07+1.14%
CTRVContraVir Pharmaceut...-0.01-0.72%
GTXIGTX Inc0.000.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$3.1M
Annual profit (last year)-$36.7M
Net profit margin-1,198.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts